Literature DB >> 15221978

Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors.

Karmen Stankov1, Alessandro Pastore, Luca Toschi, James McKay, Fabienne Lesueur, Jean Louis Kraimps, Dominique Bonneau, Hélène Gibelin, Pierre Levillain, Marco Volante, Mauro Papotti, Giovanni Romeo.   

Abstract

Hürthle thyroid tumors are characterized by frequent numerical chromosomal aberrations, including aneuploidy or polyploidy, losses and gains of some chromosomal regions and DNA fragmentation. In recent years, great attention has been paid to the combined analysis of morphologic and genetic features of oxyphilic tumors and to the elucidation of their pathogenesis. We analyzed for loss of heterozygosity (LOH) of the candidate regions for TCO (thyroid tumor with cell oxyphilia) and NMTC1 (nonmedullary thyroid carcinoma 1), 2 loci already mapped on chromosomes 19p13.2 and 2q21, respectively. Matched normal and tumor DNA samples from 70 patients with sporadic oxyphilic thyroid tumors and 20 with sporadic follicular tumors were subjected to microsatellite analysis using 10 markers on 19p13.2 and 6 markers on 2q21. This approach led us to the observation of a more significant LOH in oxyphilic than in follicular tumors. Allelic loss in tumor samples was evenly distributed in both 19p13.2 and 2q21 regions, in accordance with the established linkage of TCO and NMTC1 for inherited tumors. In order to investigate the possible contribution of both susceptibility loci in oxyphilic tumors, the family that led to the original mapping of TCO locus was reanalyzed for the markers in the 2q21 region. This led to the exclusion of linkage with the NMTC1 locus and to the refutation of the digenic inheritance hypothesis at least in this family. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221978     DOI: 10.1002/ijc.20259

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.

Authors:  Hugo João Prazeres; Fernando Rodrigues; Paula Soares; Plamen Naidenov; Paulo Figueiredo; Beatriz Campos; Manuela Lacerda; Teresa C Martins
Journal:  Fam Cancer       Date:  2007-09-07       Impact factor: 2.375

2.  Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.

Authors:  Seyed Ali Hosseini; Susan Horton; Joshua C Saldivar; Satoshi Miuma; Martha R Stampfer; Nyla A Heerema; Kay Huebner
Journal:  Genes Chromosomes Cancer       Date:  2013-08-09       Impact factor: 5.006

Review 3.  Hereditary non-medullary thyroid cancer.

Authors:  Electron Kebebew
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

4.  Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Authors:  Willem E Corver; Dina Ruano; Karin Weijers; Wietske C E den Hartog; Merlijn P van Nieuwenhuizen; Noel de Miranda; Ronald van Eijk; Anneke Middeldorp; Ekaterina S Jordanova; Jan Oosting; Ellen Kapiteijn; Guido Hovens; Jan Smit; Tom van Wezel; Hans Morreau
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

5.  Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas.

Authors:  A Fusco; G Viglietto; M Santoro
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

Review 6.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.